164 related articles for article (PubMed ID: 23037979)
21. Photocytotoxicity of hypocrellin B (HB) was enhanced by liposomalization in vitro.
Zhou Z; Zhang L; Liu H; Zhang Q; Liu B; Ai P; Ma H; Liu W; Li Z; Sheng W; Zeng Y; Zhong R
Int J Toxicol; 2011 Mar; 30(2):174-80. PubMed ID: 21536921
[TBL] [Abstract][Full Text] [Related]
22. A new sol-gel silica nanovehicle preparation for photodynamic therapy in vitro.
Zhou L; Liu JH; Zhang J; Wei SH; Feng YY; Zhou JH; Yu BY; Shen J
Int J Pharm; 2010 Feb; 386(1-2):131-7. PubMed ID: 19922781
[TBL] [Abstract][Full Text] [Related]
23. A novel photosensitizer, 2-butylamino-2-demethoxy-hypocrellin A (2-BA-2-DMHA). 1. Synthesis of 2-BA-2-DMHA and its phototoxicity to MGC803 cells.
Zhang WG; Weng M; Pang SZ; Zhang MH; Yang HY; Zhao HX; Zhang ZY
J Photochem Photobiol B; 1998 Jun; 44(1):21-8. PubMed ID: 9745725
[TBL] [Abstract][Full Text] [Related]
24. Hypocrellins as photosensitizers for photodynamic therapy: a screening evaluation and pharmacokinetic study.
Estey EP; Brown K; Diwu Z; Liu J; Lown JW; Miller GG; Moore RB; Tulip J; McPhee MS
Cancer Chemother Pharmacol; 1996; 37(4):343-50. PubMed ID: 8548880
[TBL] [Abstract][Full Text] [Related]
25. A novel hypocrellin B derivative designed and synthesized by taking consideration to both drug delivery and biological photodynamic activity.
Liu X; Xie J; Zhang L; Chen H; Gu Y; Zhao J
J Photochem Photobiol B; 2009 Mar; 94(3):171-8. PubMed ID: 19131255
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of the monomer ruthenium complex of hypocrellin B.
Zhou J; Liu J; Feng Y; Wei S; Gu X; Wang X; Zhang B
Bioorg Med Chem Lett; 2005 Jun; 15(12):3067-70. PubMed ID: 15913997
[TBL] [Abstract][Full Text] [Related]
27. Biophysical evaluation of two red-shifted hypocrellin B derivatives as novel PDT agents.
Paul BT; Babu MS; Santhoshkumar TR; Karunagaran D; Selvam GS; Brown K; Woo T; Sharma S; Naicker S; Murugesan R
J Photochem Photobiol B; 2009 Jan; 94(1):38-44. PubMed ID: 18977666
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of hypericin and hypocrellin-induced phototoxicity by omeprazole.
Mirossay A; Mirossay L; Tóthová J; Miskovský P; Onderková H; Mojzis J
Phytomedicine; 1999 Nov; 6(5):311-7. PubMed ID: 11962536
[TBL] [Abstract][Full Text] [Related]
29. Hypocrellin B enhances ultrasound-induced cell death of nasopharyngeal carcinoma cells.
Wang P; Xu CS; Xu J; Wang X; Leung AW
Ultrasound Med Biol; 2010 Feb; 36(2):336-42. PubMed ID: 20018428
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization and photodynamic activity of amino-substituted hypocrellin derivatives.
Tang YJ; Liu HY; An JY; Han R
Photochem Photobiol; 2001 Aug; 74(2):201-5. PubMed ID: 11547555
[TBL] [Abstract][Full Text] [Related]
31. Hypocrellins and Hypericin induced apoptosis in human tumor cells: a possible role of hydrogen peroxide.
Ali SM; Chee SK; Yuen GY; Olivo M
Int J Mol Med; 2002 May; 9(5):461-72. PubMed ID: 11956650
[TBL] [Abstract][Full Text] [Related]
32. Combination treatment with photodynamic therapy and curcumin induces mitochondria-dependent apoptosis in AMC-HN3 cells.
Ahn JC; Kang JW; Shin JI; Chung PS
Int J Oncol; 2012 Dec; 41(6):2184-90. PubMed ID: 23064512
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of hypocrellin pharmacokinetics in phototherapy.
Ali SM; Olivo M
Int J Oncol; 2002 Dec; 21(6):1229-37. PubMed ID: 12429972
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ROS-NF-κB-dependent autophagy enhances Hypocrellin A united LED red light-induced apoptosis in squamous carcinoma A431 cells.
Niu T; Tian Y; Wang G; Guo G; Tong Y; Shi Y
Cell Signal; 2020 May; 69():109550. PubMed ID: 32007528
[TBL] [Abstract][Full Text] [Related]
35. Antitumor efficacy of photodynamic therapy using novel nanoformulations of hypocrellin photosensitizer SL052.
Korbelik M; Madiyalakan R; Woo T; Haddadi A
Photochem Photobiol; 2012; 88(1):188-93. PubMed ID: 22070614
[TBL] [Abstract][Full Text] [Related]
36. Quantitative and site-directed chemical modification of hypocrellins toward direct drug delivery and effective photodynamic activity.
Deng H; Liu X; Xie J; Yin R; Huang N; Gu Y; Zhao J
J Med Chem; 2012 Mar; 55(5):1910-9. PubMed ID: 22352922
[TBL] [Abstract][Full Text] [Related]
37. In vitro study of the photocytotoxicity of bathochromically-shifted hypericin derivatives.
Roelants M; Lackner B; Waser M; Falk H; Agostinis P; Van Poppel H; de Witte PA
Photochem Photobiol Sci; 2009 Jun; 8(6):822-9. PubMed ID: 19492110
[TBL] [Abstract][Full Text] [Related]
38. [Hypocrellin B photosensitization effected a change of cytoplasmic free calcium concentration in ascitic hepatoma cells].
Yue JC; Pang SZ; Zhang L
Shi Yan Sheng Wu Xue Bao; 1993 Sep; 26(3):233-7. PubMed ID: 8191800
[TBL] [Abstract][Full Text] [Related]
39. External heavy-atomic construction of photosensitizer nanoparticles for enhanced in vitro photodynamic therapy of cancer.
Zhou L; Wei S; Ge X; Zhou J; Yu B; Shen J
J Phys Chem B; 2012 Oct; 116(42):12744-9. PubMed ID: 22984941
[TBL] [Abstract][Full Text] [Related]
40. Hypocrellin B-based activatable photosensitizers for specific photodynamic effects against high H
Kitamura T; Nakata H; Takahashi D; Toshima K
Chem Commun (Camb); 2021 Dec; 58(2):242-245. PubMed ID: 34850796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
